These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4632333)

  • 1. [Treatment of atherosclerosis with trilon B].
    Nikitina EK; Abramova MA
    Kardiologiia; 1972 Nov; 12(11):137-9. PubMed ID: 4632333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of atherosclerosis with cobalt-containing preparations].
    Khodzhaev AKh; Ashirmatov AE; Mirochnik LM
    Klin Med (Mosk); 1972 Jan; 50(1):77-82. PubMed ID: 5020034
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of Magnesium compositum in arteriosclerosis of the vessels of the heart, brain and lower extremities].
    Savenkov PM; Martynov AI; Kertsman GI; Bobrovskaia OB; Pogorel'skiĭ AI
    Kardiologiia; 1971 Oct; 11(10):85-91. PubMed ID: 5138051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3].
    Aslan A; Buşilă V; Sacerdoţeanu F
    Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
    Veccia F
    Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
    Caruzzo C; Enrico-Bena L; Carnaghi R
    Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of recordil-30 in arteriosclerosis of the arteries of the heart, brain and lower extremities].
    Zadionchenko VS; Savenkov PM; Martynov AI
    Kardiologiia; 1974 Apr; 14(4):108-12. PubMed ID: 4836803
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A; Solitro A; Torcia L; Arcuri P
    Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
    [No Abstract]   [Full Text] [Related]  

  • 16. Apparent failure of edetic acid chelation therapy for the treatment of coronary atherosclerosis.
    Wirebaugh SR; Geraets DR
    DICP; 1990 Jan; 24(1):22-5. PubMed ID: 2105562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of atherosclerosis patients with trylon B].
    Nikitina EK; Abramova MA
    Kardiologiia; 1972 Sep; 12(9):131-2. PubMed ID: 4630204
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.